Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations - Curik, Nikola; Laznicka, Adam; Polivkova, Vaclava; Krizkova, Jitka; Pokorna, Eva; Semerak, Pavel; Suchankova, Pavla; Burda, Pavel; Hochhaus, Andreas; Machova Polakova, Katerina (Leukemia, 2024)
Keywords: mutace; Animals; Pyridazines; inhibitory proteinkinas; bcr-abl fúzní proteiny; Pyrazoles; lidé; niacinamid; pyrazoly; chronická myeloidní leukemie; Mice; Mutation; Antineoplastic Combined Chemotherapy Protocols; Niacinamide; myši; protokoly protinádorové kombinované chemoterapie; Imidazoles; pyridaziny; Blast Crisis; Protein Kinase Inhibitors; zvířata; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Fusion Proteins, bcr-abl; blastická krize; imidazoly; Humans